The effect of peritoneal lavage with the addition of camostate to the lavage fluid on the outcome of taurocholate pancreatitis in rats was studied. Camostate is a low molecular weight protease inhibitor which has been developed recently. Peritoneal lavage was performed for 12 hours and camostate was added to the lavage fluid in five concentrations. At 0 1 mg/ml the survival rate increased significantly (11 of 20 v controls 4 of 20, p<005); the maximal effect was observed at 0-2 mg/ml, and no effect was seen at 0.01 and 0 05 mg/ml.
Peritoneal lavage is known to improve survival in experimental haemorrhagic pancreatitis in several species.' Although its benefit for humans has not been proved,' peritoneal lavage without the addition of protease inhibitors is a therapeutic regimen for severe acute pancreatitis' and is routinely performed in some European centres. 3 Intravenous or subcutaneous injection of the recently developed synthetic protease inhibitors camostate and gabexate mesilate has been tested in several forms of acute experimental pancreatitis. 3 The combination of systemic application of Amylase activity in plasma was quantified colorimetrically6 using a commercial kit (Phadebas Amylase Test, Pharmacia Diagnostics AG, Uppsala, Sweden).
Pancreatic tissue for histology was fixed in formalin, embedded in paraplast, and 4 ,um slices were stained with haematoxylin and eosin. Examination by light microscopy was performed blind as to whether the section was from the treatment or the control group. The extents of necrosis, oedema, haemorrhage, leucocyte infiltration, and vacuolisation of acinar cells were used as histological parameters for grading the specific tissue damage to the pancreas.4
The unpaired and two tailed t test was used for comparison of biochemical data.
Results

FEASIBILITY OF THE LAVAGE PROTOCOL
The regimen for the lavage of blocking the catheter for 15 (Fig 3, p<0-01 
